Ariadne Labs founder and executive director Dr. Atul Gawande has been named the CEO of the new Amazon, JPMorgan Chase, Berkshire Hathaway nonprofit health care organization and will transition to a new role as chairman of Ariadne Labs. He will remain a practicing surgeon at Brigham and Women’s Hospital and a professor at Harvard T.H. Chan School of Public Health and Harvard Medical School.
The new appointment was announced Wednesday jointly by Amazon CEO Jeff Bezos, Berkshire Hathaway CEO Warren Buffett, and JPMorgan Chase CEO Jamie Dimon. “We said at the outset that the degree of difficulty is high and success is going to require an expert’s knowledge, a beginner’s mind, and a long-term orientation,” said Mr. Bezos. “Atul embodies all three, and we’re starting strong as we move forward in this challenging and worthwhile endeavor.”
A national search will be launched for a new successor to lead Ariadne, a joint center for health systems innovation of Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health. Dr. Gawande will transition from executive director to chairman when a new leader is selected. He will also continue to write, including for The New Yorker magazine.
“I am thrilled about this opportunity as it aligns perfectly with my personal mission,” Dr. Gawande said. “I have devoted my public health career to working with colleagues to build scalable solutions for better health care delivery in the U.S. and across the world. Now, I have the support of these remarkable organizations to pursue this mission for their employees and families in ways that incubate better models of care for all. And I will be able to do so while maintaining my own voice and continuing to enable Ariadne Labs’ powerful and complementary work.”